Bristlecone Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,219
Closed -$365K 208
2020
Q4
$365K Hold
2,219
0.06% 161
2020
Q3
$277K Buy
+2,219
New +$275K 0.05% 161
2020
Q1
Sell
-2,300
Closed -$340K 171
2019
Q4
$340K Buy
+2,300
New +$309K 0.07% 163
2019
Q3
Sell
-2,154
Closed -$291K 153
2019
Q2
$291K Buy
+2,154
New +$272K 0.07% 151
2016
Q4
Sell
-5,615
Closed -$425K 157
2016
Q3
$425K Buy
5,615
+50
+0.9% +$3.83K 0.15% 116
2016
Q2
$429K Buy
5,565
+240
+5% +$18.9K 0.16% 104
2016
Q1
$416K Sell
5,325
-250
-4% -$17.5K 0.16% 117
2015
Q4
$377K Buy
+5,575
New +$389K 0.16% 122

Other funds holding HCA

Bristlecone Advisors's HCA Position: Q1 2021 in Review

Bristlecone Advisors sold out of HCA Healthcare (HCA) in Q1 2021, closing a stake of 2,219 shares — an estimated $365K sold.

Bristlecone Advisors first reported a position in HCA in Q4 2015 and held it in 8 quarters. The position peaked at $429K in Q2 2016. 786 funds tracked by Wall St. Rank hold HCA as of Q1 2021.

  • Bristlecone Advisors reported no remaining HCA Healthcare position as of Q1 2021 after selling out during the quarter.
  • Bristlecone Advisors sold 2,219 HCA Healthcare shares in Q1 2021, an estimated $365K.
  • Bristlecone Advisors first reported a position in HCA Healthcare in Q4 2015 and held it in 8 quarters.
  • Bristlecone Advisors's HCA Healthcare position peaked at $429K in Q2 2016.
  • 786 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2021.

Based on Bristlecone Advisors's 13F filing for Q1 2021, filed 30 Apr 2021.